However, due to the invasive nature of colorectal cancer and the high cost of treatment, and the possible side effects such as bleeding, epigenetic factors including DNA methylation, such as VIM gene methylation, SFRP2 methylation, etc., have broad prospects for the future diagnosis and prediction of CRC (Jung et al., 2020). Here, SFRP2 is linked to colorectal cancer.